This inventor holds 1 USPTO granted patent. Top assignee: G.d. Searle & Company. Active years: 1990.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1990
Title: Bonita J Rup: Innovator in Monoclonal Antibodies
Introduction
Bonita J Rup is a distinguished inventor based in St. Louis, MO (US). She has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. Her innovative work has the potential to impact various medical applications.
Latest Patents
Bonita holds a patent for "Monoclonal antibodies against IgE-associated determinants, hybrid cell." This invention is directed to monoclonal antibodies and hybridomas that produce them. These antibodies react with IgE when it is unbound, inhibiting IgE binding to mast cells. Additionally, they react with IgE when it is bound to the B-cell FcE receptor, but do not react with IgE when it is bound to the mast cell FcE receptor. This patent showcases her expertise and dedication to advancing medical science. She has 1 patent to her name.
Career Highlights
Bonita is currently associated with G.D. Searle & Company, where she continues her research and development efforts. Her work at this company has allowed her to collaborate with other talented professionals in the field.
Collaborations
One of her notable coworkers is Larry E Kahn, with whom she has likely shared insights and expertise in their research endeavors.
Conclusion
Bonita J Rup is a remarkable inventor whose work in monoclonal antibodies demonstrates her commitment to innovation in biotechnology. Her contributions are paving the way for advancements in medical treatments and therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile